In its contingent cross-appeal from the Patent Trial and Appeal Board's (PTAB) adverse decision on priority against Junior Party the University of California/Berkeley, the University of.
Holding In Newron Pharms. v. Aurobindo, No. 21-cv-843 , the District Court of Delaware addressed several disputed terms in a patent related to the treatment of idiopathic Parkinson s disease. Based. | June 14, 2023
In Genuine Enabling Technology LLC v. Nintendo Co., Ltd., the Federal Circuit held that statements made during prosecution to distinguish the prior art on the ground that it taught.